Foxf2 in Intestinal Fibroblasts Reduces Numbers of Lgr5(+) Stem Cells and Adenoma Formation by Inhibiting Wnt Signaling

Dept of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Gastroenterology (Impact Factor: 16.72). 01/2013; 144(5). DOI: 10.1053/j.gastro.2013.01.045
Source: PubMed


Background & aims:
The stem cell niche at the base of the intestinal crypts, as well as stemness and high clonogenicity in colon cancer cells, depend on Wnt signaling to β-catenin. Fibroblasts modulate the Wnt pathway in normal and neoplastic epithelial cells via unclear mechanisms. We investigated how in intestinal fibroblasts the forkhead transcription factor Foxf2 controls Wnt signaling to affect numbers of stem cells and formation and growth of adenomas in mice.

We created mice with different copy numbers of Foxf2 by generating Foxf2(-/+) mice and a transgenic strain, Tg(FOXF2). Adenoma formation was investigated in Apc(Min/+) mice, stem cells were counted in mice with the Lgr5-enhanced green fluorescent protein knock-in allele, proliferation was measured by incorporation of bromodeoxyuridine, Foxf2 and Sfrp1 were localized by immunohistochemistry, and signaling pathways were analyzed by quantitative polymerase chain reaction and immunoblot assays.

Epithelial β-catenin was stabilized in Foxf2(-/+) mice, resulting in increased number and size of adenomas. Tg(FOXF2) mice, however, were partially resistant to intestinal neoplasia and developed fewer and smaller adenomas; Foxf2(-/+) mice developed 24-fold more tumors than Tg(FOXF2) mice. Epithelial cells of Foxf2(-/+) mice also had higher numbers of Lgr5(+) stem cells and greater amounts of crypt cell proliferation and expression of Myc (a target of Wnt signaling) than Tg(FOXF2) mice. Expression of Sfrp1, which encodes an extracellular inhibitor of Wnt, in fibroblasts increased with copy number of Foxf2.

Foxf2 is a fibroblast factor that inhibits paracrine Wnt signaling and restricts the crypt stem cell niche in intestines of mice. Loss of Foxf2 promotes adenoma formation and growth.

Download full-text


Available from: Peter Carlsson
  • Source
    • "Histologically, the gastrointestinal tract is composed of 5 layers that consist of the lamina propria, submucosa, muscular layer, subserosa, and serosa. Loose connective tissue and fibroblasts exist in every layer and have distinct physiological and pathological functions [19],[20]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Peritoneal invasion in colon cancer is an important prognostic factor. Peritoneal invasion can be objectively identified as periotoneal elastic laminal invasion (ELI) by using elastica stain, and the cancer microenvironment formed by the peritoneal invasion (CMPI) can also be observed. Cases with ELI more frequently show distant metastasis and recurrence. Therefore, CMPI may represent a particular milieu that facilitates tumor progression. Pathological and biological investigations into CMPI may shed light on this possibly distinctive cancer microenvironment.
    Full-text · Article · Feb 2014 · PLoS ONE
  • Source
    • "However , prior work from Kaestner and co-workers showed that the FOXF1 and FOXL1 homeobox genes in stromal cells mediate Hh ligand-mediated suppression of Wnt signaling. More recently, Ihh regulation of Foxf2 was shown to inhibit intestinal polyp development , consistent with the prior observation that canonical activation of these Forkhead homeobox genes in stromal cells suppresses epithelial proliferation [89] [90]. Collectively, these studies suggest that FOX transcription factors activate a program of genes in stromal cells that inhibits epithelial proliferation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This review summarizes emerging information regarding the Hedgehog (Hh) signaling pathway during neoplastic transformation in the gastrointestinal tract. Although there is a role for the well-established canonical pathway in which Hedgehog ligands interact with their receptor Patched, there is sufficient evidence that downstream components of the Hh pathway, e.g., Gli1, are hijacked by non-Hh signaling pathways to promote the conversion of the epithelium to dysplasia and carcinoma. We review the canonical pathway and involvement of primary cilia, and then focus on current evidence for Hh signaling in luminal bowel cancers as well as accessory organs, i.e., liver, pancreas and biliary ducts. We conclude that targeting the Hh pathway with small molecules, nutriceuticals and other mechanisms will likely require a combination of inhibitors that target Gli transcription factors in addition to canonical modulators such as Smoothened.
    Full-text · Article · Aug 2013 · Cancer Treatment Reviews
  • Source
    • "SHH signaling through the stroma is critical for tumor growth with key reciprocal feedback from the stroma to promote epithelial WNT and IGF signaling [45]. Potential SHH targets in the stromal cells include important stromal effectors such as forkhead transcription factors [46] and Gremlin 1 [1] [21]. Gremlin 1 is a well recognized BMP antagonist in the cancer microenvironment and is another GLI1, and thus possible HH signaling, target [47]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer is a systemic disease. Local and distant factors conspire to promote or inhibit tumorigenesis. The bone marrow is one important source of tumor promoting cells. These include the important mature and immature hematopoietic cells as well as circulating mesenchymal progenitors. Recruited bone marrow cells influence carcinogenesis at the primary site, within the lymphoreticular system and even presage metastasis through their recruitment to distant organs. In this review we focus on the origins and contribution of cancer-associated fibroblasts in tumorigenesis. Mesenchymal cells present an important opportunity for targeted cancer prevention and therapy.
    Full-text · Article · Mar 2013 · Experimental Cell Research
Show more